Insider buying
~$24K8,000 sh @ $2.98
Traded Oct 23 · filed 3 days later
An Anixa Biosciences director paid $24K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 30, 2026 · Filed Sep 30, 2026
The CFO of Anixa Biosciences paid $16K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month. It was the first purchase in 20 months.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$15,620
Shares × reported transaction price
<$25K
+12.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 20 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 1.2% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2025 ($1.3M)
An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-01-28. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement
Closed at $2.93 on Sep 30, 2026, 25% above its 52-week low and 44% below its high, after a 15% drop over the previous 30 trading days
52-week range $2.35 (Jun 10, 2026) to $5.22 (Dec 8, 2025), 20% of the way up, from 251 adjusted closes. 30 trading days earlier: $3.43 on Aug 18, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
3 ANIX insiders bought within the same week. That happened 15 times before in filings since 2006, most recently Jan 2025
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.0% | +1.3% | +3.8% |
| 30 days | +7.9% | −1.6% | +9.5% |
Past results only. Not a forecast.
Insider buying
Traded Oct 23 · filed 3 days later
An Anixa Biosciences director paid $24K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Insider buying
Traded Oct 22 · filed the same day
The CEO of Anixa Biosciences paid $22K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Insider buying
3 insiders in a week, 16th time since 2006Traded Sep 24 · filed 4 days later
The CEO of Anixa Biosciences paid $19K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.